• Search
  • Advanced Search

Review

October 5, 2021


The management of post-transplantation recurrence of hepatocellular carcinoma
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, et al.
Clin Mol Hepatol. 2022;28(1):1-16.

The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades, liver transplantation (LT) has become the preferable treatment of HCC, when feasible and strict selection...

Review

July 20, 2021


Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Sun Woong Kim, Jun Sik Yoon, Minjong Lee, et al.
Clin Mol Hepatol. 2022;28(1):17-30.

Hepatitis B virus (HBV) affects approximately 250 million patients worldwide, resulting in the progression to cirrhosis and hepatocellular carcinoma, which are serious public health problems. Although universal vaccination programs exist,...

Review

August 2, 2021


Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol. 2022;28(1):31-46.

Acute kidney injury (AKI) is common in advanced cirrhosis. Prerenal azotemia, hepatorenal syndrome, and acute tubular necrosis are the main causes of AKI in patients with cirrhosis. Evaluation of renal...

Original Article

September 17, 2021


Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
Hydar El Jamaly, Guy D Eslick, Martin Weltman
Clin Mol Hepatol. 2022;28(1):52-66.

Background/Aims: Maternal and fetal outcomes in pregnant patients with Non-alcoholic fatty liver disease (NAFLD) have been largely unexplored. To determine the level of evidence associated with maternal and fetal outcomes...

Original Article

October 12, 2021


Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Hyung-Don Kim, Seon-Ok Kim, et al.
Clin Mol Hepatol. 2022;28(1):67-76.

Background/Aims: We aimed to investigate the silent atherosclerotic burden of cervicocephalic vessels in cirrhotic patients compared with the general population, as well as the relevant risk factors including coronary parameters. Methods:...

Original Article

November 5, 2021


U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, et al.
Clin Mol Hepatol. 2022;28(1):77-90.

Background/Aims: We aimed to determine the association between blood urea level and incident cirrhosis, hepatic decompensation, and hepatocellular carcinoma in chronic liver disease (CLD) patients. Methods: The association between blood urea...

Original Article

November 5, 2021


A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, et al.
Clin Mol Hepatol. 2022;28(1):91-104.

Background/Aims: This study aimed to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening compared to no screening in the Korean population from societal and healthcare system perspectives. Methods: A published...

Original Article

October 15, 2021


Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, et al.
Clin Mol Hepatol. 2022;28(1):105-116.

Background/Aims: To develop an early prediction model for gestational diabetes mellitus (GDM) using machine learning and to evaluate whether the inclusion of nonalcoholic fatty liver disease (NAFLD)-associated variables increases the...
Current Issue
Volume 28(1); Jan 2022
Review
1637
The management of post-transplantation recurrence of hepatocellular carcinoma
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin
Clin Mol Hepatol. 2022;28(1):1-16.   Published online October 5, 2021
1624
Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
Clin Mol Hepatol. 2022;28(1):17-30.   Published online July 20, 2021
1626
Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol. 2022;28(1):31-46.   Published online August 2, 2021
Editorial
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Seung Mi Lee, Won Kim
Clin Mol Hepatol. 2022;28(1):47-49.   Published online November 30, 2021
Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
Ja-Young Kwon
Clin Mol Hepatol. 2022;28(1):50-51.   Published online November 22, 2021
Original Article
1633
Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
Hydar El Jamaly, Guy D Eslick, Martin Weltman
Clin Mol Hepatol. 2022;28(1):52-66.   Published online September 17, 2021
1638
Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim
Clin Mol Hepatol. 2022;28(1):67-76.   Published online October 12, 2021
1642
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2022;28(1):77-90.   Published online November 5, 2021
1643
A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong
Clin Mol Hepatol. 2022;28(1):91-104.   Published online November 5, 2021
1639
Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park
Clin Mol Hepatol. 2022;28(1):105-116.   Published online October 15, 2021
Snapshot
1650
Current status and outcome of liver transplantation in South Korea
Ho Joong Choi
Clin Mol Hepatol. 2022;28(1):117-119.   Published online December 7, 2021

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

ABOUT
BROWSE ARTICLES
CURRENT ISSUE
FOR CONTRIBUTORS
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 303
TOTAL : 698009
Close layer